Raanana, Israel

Mich El M Afargan

This inventor holds 1 USPTO granted patent. Top assignee: Peptor Limited. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mich El M Afargan. Retrieved from https://idiyas.com/inventor/mich-el-m-afargan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Mich El M Afargan

Introduction

Mich El M Afargan, an accomplished inventor based in Raanana, Israel, has made significant contributions to the field of peptide research. With one patent to his name, he continues to push the boundaries of scientific innovation.

Latest Patents

Afargan's notable patent, titled "Conformationally constrained backbone cyclized somatostatin analogs," showcases his expertise in developing novel peptides. This patent describes methods for synthesizing somatostatin analogs and producing libraries of these compounds. Furthermore, it highlights pharmaceutical compositions comprising these analogs and methods for utilizing them in various applications.

Career Highlights

Mich El M Afargan works at Peptor Limited, a company specializing in peptide-based therapeutics. His dedication to the advancement of peptide research has been a driving force in his career, positioning him as a key figure in the development of innovative solutions.

Collaborations

Throughout his career, Afargan has collaborated with talented coworkers, including Vered Hornik and Gary Gellerman. These partnerships have undoubtedly contributed to his innovative work and the success of his projects.

Conclusion

In summary, Mich El M Afargan's contributions to peptide research and his innovative patent position him as a noteworthy inventor in the scientific community. His work at Peptor Limited and collaborations with skilled professionals reflect his commitment to advancing the field and developing impactful therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…